Atkinson Edward Morrow III bought VRTX
May 14, 2024 · Form 4 insider transaction
Atkinson Edward Morrow III bought 14,112 shares of Vertex Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,112
Price
$0.00
Total value
N/A
InsiderAtkinson Edward Morrow III
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 14, 2024
Filing dateMay 16, 2024
Shares owned after30,084
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents earned performance shares with respect to a performance stock unit award granted on 05/19/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 05/14/2024 and the shares will vest on 06/10/2024.